D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Global Class C
LBTYK
|
+$404M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$361M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$327M |
| 4 |
Procter & Gamble
PG
|
+$313M |
| 5 |
Netflix
NFLX
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
Bank of America
BAC
|
+$405M |
| 3 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$236M |
| 4 |
Citigroup
C
|
+$219M |
| 5 |
SLB Ltd
SLB
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.97% |
| 2 | Communication Services | 9.3% |
| 3 | Healthcare | 8.21% |
| 4 | Consumer Discretionary | 8.05% |
| 5 | Energy | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Amphenol
APH
$192B
| $302K | ﹤0.01% |
+52,800
| New | +$294K |
|
|
AXON
3877
CALL
Axon Enterprise
AXON
$36.7B
| $302K | ﹤0.01% |
16,500
| – | – |
|
|
BCPC
3878
Balchem Corp
BCPC
$5.33B
| $302K | ﹤0.01% |
+5,800
| New | +$311K |
|
|
ATW
3879
CALL
DELISTED
Atwood Oceanics
ATW
| $302K | ﹤0.01% |
6,000
-4,000
| -40% | -$194K |
|
3880
CEVA Inc
CEVA
$838M
| $301K | ﹤0.01% |
+17,156
| New | +$294K |
|
3881
Pacific Biosciences
PACB
$429M
| $301K | ﹤0.01% |
56,209
+15,940
| +40% | +$101K |
|
|
LHCG
3882
DELISTED
LHC Group LLC
LHCG
| $301K | ﹤0.01% |
+13,649
| New | +$318K |
|
|
XRM
3883
DELISTED
Xerium Technologies Inc (new)
XRM
| $301K | ﹤0.01% |
18,766
-573
| -3% | -$9.34K |
|
3884
PUT
Ubiquiti
UI
$36B
| $300K | ﹤0.01% |
+6,600
| New | +$309K |
|
3885
CALL
Newell Brands
NWL
$2.4B
| $299K | ﹤0.01% |
10,000
| – | – |
|
|
AUO
3886
DELISTED
AU Optronics Corp
AUO
| $298K | ﹤0.01% |
+85,621
| New | +$268K |
|
3887
Mattel
MAT
$3.81B
| $295K | ﹤0.01% |
7,356
-124,937
| -94% | -$4.96M |
|
|
IMPV
3888
PUT
DELISTED
Imperva, Inc.
IMPV
| $295K | ﹤0.01% |
+5,300
| New | +$305K |
|
3889
HSBC
HSBC
$352B
| $294K | ﹤0.01% |
6,720
| – | – |
|
3890
Park National Corp
PRK
$3.33B
| $294K | ﹤0.01% |
3,822
-2,453
| -39% | -$193K |
|
|
ADVS
3891
CALL
DELISTED
Advent Software Inc
ADVS
| $294K | ﹤0.01% |
10,000
-38,100
| -79% | -$1.21M |
|
3892
ANI Pharmaceuticals
ANIP
$1.71B
| $293K | ﹤0.01% |
+9,340
| New | +$248K |
|
3893
PUT
Broadridge
BR
$18.8B
| $293K | ﹤0.01% |
7,900
-79,100
| -91% | -$2.97M |
|
3894
Mueller Water Products
MWA
$3.44B
| $293K | ﹤0.01% |
30,805
-153,476
| -83% | -$1.41M |
|
|
LUMO
3895
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $293K | ﹤0.01% |
1,144
-5,443
| -83% | -$1.66M |
|
|
TREC
3896
DELISTED
Trecora Resources
TREC
| $293K | ﹤0.01% |
26,986
-20,013
| -43% | -$239K |
|
3897
ArcBest
ARCB
$2.91B
| $292K | ﹤0.01% |
+7,900
| New | +$269K |
|
3898
CALL
Petrobras
PBR
$135B
| $292K | ﹤0.01% |
22,200
-405,300
| -95% | -$4.73M |
|
|
ANAC
3899
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $291K | ﹤0.01% |
14,533
-37,281
| -72% | -$723K |
|
|
CADE
3900
PUT
DELISTED
Cadence Bank
CADE
| $290K | ﹤0.01% |
11,600
-16,300
| -58% | -$397K |
|
Similar funds
D.E. Shaw & Co's Q1 2014 Portfolio in Review
As of Q1 2014, D.E. Shaw & Co held 5,020 positions worth $70.1B, down 4.4% from $73.3B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co deployed $3.3B of net new capital in Q1 2014, opening 596 new positions and adding to 1,359 existing holdings. Its largest new stake was Veren: 1,596,878 shares worth $53.3M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 44% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $453M trimmed.
- D.E. Shaw & Co's largest Q1 2014 buy was Veren: 1,596,878 shares worth $53.3M.
- D.E. Shaw & Co added most to Liberty Global Class C in Q1 2014, an estimated $404M increase.
- D.E. Shaw & Co's biggest Q1 2014 reduction was Apple, cutting an estimated $453M.
- D.E. Shaw & Co fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $236M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $70.1B portfolio in Q1 2014.
- D.E. Shaw & Co opened 596 new positions and closed 795 in Q1 2014.
- D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $70.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2014, filed 15 May 2014.